Parallel Industries Inc. does not have significant operations. Previously, the company was involved in development and markets various topically delivered drugs to treat cancer and other therapeutic products to treat various conditions. It focuses on development, licenses, production, and markets prescription and over-the-counter products. The company was formerly known as Easton Pharmaceuticals I...
Parallel Industries reported revenue of $0 for fiscal year 2020, down 100.0% from fiscal year 2019, and net income of -$188,542. In Q3 2021 (the quarter ended September 30, 2021) revenue was $0.
Figures from company filings; latest fiscal year ended December 31, 2020.
No profile data available.